The Aim and objective of the study is to evaluate the comparative effectiveness of pelvic interferential therapy (PIFT) and transcutaneous posteriortibial nerve stimulation (PTNS) on volume at first detrusor contraction, detrusor pressure of neurogenic detrusor overactivity (NDO), number of leakagesand incontinence on ICIQ-UI-SF scale in spinal cord injury patients (SCI) with neurogenic detrusor overactivity (NDO) associated incontinence. In thisrandomized clinical trial, 33 SCI subjects with NDO with subjective complaints of frequent urination and leakages participated. Subjects were randomizedinto 3 groups: Pelvic IFT (Group1), Transcutaneous PTNS (Group 2), and control (Group3). Electrical stimulation using interferential therapy andtranscutaneous posterior tibial nerve stimulation using TENS. Antimuscarinic drugs and behavioral training were given to both group 1 and group 2. Electricalstimulation was given to both groups for 20 minutes 5 times a week for 4 weeks. At the same time, the control group (group 3) received only antimuscarinicdrugs and behavioral training. Pre-intervention and post-intervention recording of the urodynamic study (UDS) was performed, and volume at first detrusorcontraction and detrusor pressure was noted. Subjects were asked to complete the ICIQ-UI-SF scale before and after the treatment for several leakages andincontinence measurements. On comparing the three groups, there is no statistically significant difference in several leakages, detrusor pressure, and volumeat first detrusor contraction, which means all three treatments had the same effect on these outcomes. Still, there is a statistically significant difference inincontinence. The mean value of PIFT (Group1) is lesser than PTNS (Group-2) and control (Group-3). Pelvic Interferential therapy is clinically more effectivein reducing urinary incontinence episodes than transcutaneous posterior tibial nerve stimulation and anticholinergic drugs in patients with spinal cord injury.Pelvic Interferential therapy is easy to use, clinically effective, and safe with no significant side effects, and it can be easily combined with antimuscarinic drugsand behavioral training.

1. Alizadeh A, Dyck SM, Karimi-Abdolrezaee S. Traumatic spinal cord injury: an overview of pathophysiology, models and acute injury mechanisms. Front Neurol. 2019;10:282. doi: 10.3389/fneur.2019.00282, PMID 30967837.
2. Ginsberg D. The epidemiology and pathophysiology of neurogenic bladder. Am J Manag Care. 2013;19(10);Suppl:s191-6. PMID 24495240.
3. Stohrer M, Goepel M, Koneurogenic Detrusor Overactivity A, Kramer G, Madersbacher H, Millard R, Rosssey A, Wyndaele JJ. The standardization of terminology in neurogenic lower urinary tract dysfunction with suggestions for diagnostic procedures. Neurourol Urodyn. 1999;18:139-158.
4. Kamboonlert K, Panyasriwanit S, Tantisiriwat N, Kitisomprayoonkul W. Effects of bilateral transcutaneous tibial nerve stimulation on neurogenic detrusor overactivity in spinal cord injury: a urodynamic study. Arch Phys Med Rehabil. 2021;102(6):1165-9. doi: 10.1016/j.apmr.2020.10.130, PMID 33245938.
5. Panicker JN, Fowler CJ, Kessler TM. Lower urinary tract dysfunction in the neurological patient: clinical assessment and management. Lancet Neurol. 2015 July 1;14(7):720-32. doi: 10.1016/S1474-4422(15)00070-8, PMID 26067125.
6. Benevento BT, Sipski ML. Neurogenic bladder, neurogenic bowel, and sexual dysfunction in people with spinal cord injury. Phys Ther. 2002 June 1;82(6):601-12. doi: 10.1093/ptj/82.6.601, PMID 12036401.
7. Linsenmeyer TA, Bodner DR, Creasy GH, Bruce G, Groah S, Joseph A et al. Bladder management for adults with spinal cord injury: a clinical practice guideline for healthcare providers. J Spinal Cord Med. 2006;29(5):527-73. PMID 17274492.
8. Huang ST. The role of antimuscarinics in the treatment of neurogenic detrusor overactivity in patients with stroke, spinal cord injury, and Parkinson’s disease. Incontinence Pelvic Floor Dysfunct. 2008;2;Suppl 1:25-8.
9. Sahai A, Khan MS, Gregson N, Smith K, Dasgupta P, GKT Botulinum Study Group. Botulinum toxin for detrusor overactivity and symptoms of overactive bladder: where we are now and where we are going. Nat Clin Pract Urol. 2007;4(7):379-86. doi: 10.1038/ncpuro0839, PMID 17615549.
10. Vignes JR, Gimbert E, Sesay M, De Seze M, Guérin J, Joseph PA. Treatment of overactive bladder. Operative Techniques in Neurosurgery. 2004;7(3)(3):163-74. doi: 10.1053/j.otns.2005.01.006.
11. Kabay SC, Yucel M, Kabay S. Acute effect of posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with multiple sclerosis: urodynamic study. Urology. 2008;71(4):641-5. doi: 10.1016/j.urology.2007.11.135, PMID 18387393.
12. Birkhäuser V, Liechti MD, Anderson CE, Bachmann LM, Baumann S, Baumberger M, et al. Taspinal cord injury-transcutaneous tibial nerve stimulation in patients with acute spinal cord injury to prevent neurogenic detrusor overactivity: protocol for a nationwide, randomized, sham-controlled, double-blind clinical trial. BMJ Open. 2020;10(8):e040729.
13. McGuire E, Chun ZS, Horwinski ER, Lytton B. Treatment of motor and sensory detrusor and sensory detrusor instability by electrical stimulation. J Urol. 1983;129:78-9.
14. Kajbafzadeh AM, Sharifi-Rad L, Baradaran N, Nejat F. Effect of pelvic floor interferential electrostimulation on urodynamic parameters and incontinence of children with myelomeningocele and detrusor overactivity. Urology. 2009;74(2):324-9. doi: 10.1016/j.urology.2008.12.085, PMID 19476983.
15. Oh H. Neuromodulation in management of overactive bladder; December 2011.
16. Patil SP, Nagrale AV, Ganvir SD. Additive effect of interferential therapy over pelvic floor exercises. Int J Ther Rehabil. November 2010;17(11):596-602. doi: 10.12968/ijtr.2010.17.11.79540.
17. Buhroo AM. Role of interferential therapy in rehabilitation of neurogenic bladder in patients with traumatic spinal cord injuries. JK Pract. 2011;16(1-2):24-6.
18. Al-Shenqiti AM, Ragab WM, Rostum EH, Emara HA, Khaled OA. Effects of behavioral therapy versus interferential current on bladder dysfunction in multiple sclerosis patients: a randomized clinical study. J Taibah Univ Med Sci. 2021;16(6):812-8. doi: 10.1016/j.jtumed.2021.08.003, PMID 34899124.